These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 19386026

  • 1. Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue.
    Kudo H, Yata Y, Takahara T, Kawai K, Nakayama Y, Kanayama M, Oya T, Morita S, Sasahara M, Mann DA, Sugiyama T.
    Liver Int; 2009 Aug; 29(7):988-96. PubMed ID: 19386026
    [Abstract] [Full Text] [Related]

  • 2. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.
    Luo XY, Takahara T, Kawai K, Fujino M, Sugiyama T, Tsuneyama K, Tsukada K, Nakae S, Zhong L, Li XK.
    Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786
    [Abstract] [Full Text] [Related]

  • 3. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
    Sugino H, Kumagai N, Watanabe S, Toda K, Takeuchi O, Tsunematsu S, Morinaga S, Tsuchimoto K.
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
    [Abstract] [Full Text] [Related]

  • 4. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
    Kitamura K, Tada S, Nakamoto N, Toda K, Horikawa H, Kurita S, Tsunematsu S, Kumagai N, Ishii H, Saito H, Hibi T.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice.
    Kato J, Koda M, Kishina M, Tokunaga S, Matono T, Sugihara T, Ueki M, Murawaki Y.
    Int J Mol Med; 2012 Jul; 30(1):107-13. PubMed ID: 22469867
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
    Baeck C, Wehr A, Karlmark KR, Heymann F, Vucur M, Gassler N, Huss S, Klussmann S, Eulberg D, Luedde T, Trautwein C, Tacke F.
    Gut; 2012 Mar; 61(3):416-26. PubMed ID: 21813474
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [Abstract] [Full Text] [Related]

  • 9. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW, Sahai A, Malladi P, Whitington PF, Green RM.
    J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
    [Abstract] [Full Text] [Related]

  • 10. Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.
    Kaji K, Yoshiji H, Kitade M, Ikenaka Y, Noguchi R, Shirai Y, Aihara Y, Namisaki T, Yoshii J, Yanase K, Tsujimoto T, Kawaratani H, Fukui H.
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1094-104. PubMed ID: 21372165
    [Abstract] [Full Text] [Related]

  • 11. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [Abstract] [Full Text] [Related]

  • 12. Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.
    Yoshida T, Akiba J, Matsui T, Nakamura K, Hisamoto T, Abe M, Ikezono Y, Wada F, Iwamoto H, Nakamura T, Koga H, Yamagishi SI, Torimura T.
    Dig Dis Sci; 2017 Jun; 62(6):1527-1536. PubMed ID: 28365916
    [Abstract] [Full Text] [Related]

  • 13. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF, Purushotham A, Wendel AA, Belury MA.
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [Abstract] [Full Text] [Related]

  • 14. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis.
    Uno M, Kurita S, Misu H, Ando H, Ota T, Matsuzawa-Nagata N, Kita Y, Nabemoto S, Akahori H, Zen Y, Nakanuma Y, Kaneko S, Takamura T.
    Hepatology; 2008 Jul; 48(1):109-18. PubMed ID: 18571789
    [Abstract] [Full Text] [Related]

  • 15. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
    Tomita K, Oike Y, Teratani T, Taguchi T, Noguchi M, Suzuki T, Mizutani A, Yokoyama H, Irie R, Sumimoto H, Takayanagi A, Miyashita K, Akao M, Tabata M, Tamiya G, Ohkura T, Hibi T.
    Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257
    [Abstract] [Full Text] [Related]

  • 16. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis.
    Asano T, Watanabe K, Kubota N, Gunji T, Omata M, Kadowaki T, Ohnishi S.
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1669-76. PubMed ID: 19788607
    [Abstract] [Full Text] [Related]

  • 17. Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice.
    Fujisaka S, Usui I, Kanatani Y, Ikutani M, Takasaki I, Tsuneyama K, Tabuchi Y, Bukhari A, Yamazaki Y, Suzuki H, Senda S, Aminuddin A, Nagai Y, Takatsu K, Kobayashi M, Tobe K.
    Endocrinology; 2011 May; 152(5):1789-99. PubMed ID: 21427223
    [Abstract] [Full Text] [Related]

  • 18. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
    Larter CZ, Yeh MM, Williams J, Bell-Anderson KS, Farrell GC.
    J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
    [Abstract] [Full Text] [Related]

  • 19. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.
    Jung YA, Choi YK, Jung GS, Seo HY, Kim HS, Jang BK, Kim JG, Lee IK, Kim MK, Park KG.
    Diabetes Res Clin Pract; 2014 Jul; 105(1):47-57. PubMed ID: 24842243
    [Abstract] [Full Text] [Related]

  • 20. Deletion of angiotensin II type I receptor reduces hepatic steatosis.
    Nabeshima Y, Tazuma S, Kanno K, Hyogo H, Chayama K.
    J Hepatol; 2009 Jun; 50(6):1226-35. PubMed ID: 19395110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.